Clinical Trial Update: Efficacy Evaluation of Shen Cao Gan Jiang Tang on Mild and Moderate COVID-19 Patients [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update evaluating Shen Cao Gan Jiang Tang for efficacy in mild to moderate COVID-19 patients (Phase 2/Phase 3).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Infection

Drugs mentioned

• Shen Cao Gan Jiang Tang

Snippet

Sponsor: University of Medicine and Pharmacy at Ho Chi Minh City | Conditions: COVID-19 Respiratory Infection, Herbal Medicine | Phase 2, Phase 3 | Status: COMPLETED